Non‐O157 Shiga Toxin–ProducingEscherichia coliInfections in the United States, 1983–2002
The Journal of Infectious Diseases2005Vol. 192(8), pp. 1422–1429
Citations Over TimeTop 1% of 2005 papers
John T. Brooks, Evangeline G. Sowers, Joy G. Wells, Katherine D. Greene, Patricia M. Griffin, Robert M. Hoekstra, Nancy Strockbine
Abstract
Non-O157 STEC can cause severe illness that is comparable to the illness caused by STEC O157. Strains that produce Shiga toxin 2 are much more likely to cause HUS than are those that produce Shiga toxin 1 alone. Improving surveillance will more fully elucidate the incidence and pathological spectrum of these emerging agents. These efforts require increased clinical suspicion, improved clinical laboratory isolation, and continued serotyping of isolates in public health laboratories.
Related Papers
- Bacteriostatic Experiment of Twelve Species of Chinese Medicines and Its Compounds Against Escherichia Coli(2004)
- Effect of Mitomycin C on the Expression of Shiga Toxin from Escherichia coli O157(2008)
- Damaging effect of pressurized CO_2 on cell membrane of Escherichia coli(2013)
- → A putative microcin amplifies Shiga toxin 2a production of Escherichia coli O157:H7(2019)
- A study on β-lactamase activity of biofilm Escherichia coli(2001)